Remove Big data Remove Healthcare Remove How To Remove Security
article thumbnail

How to protect healthcare and life-sciences data from a cyber attack pandemic

Thales Cloud Protection & Licensing

How to protect healthcare and life-sciences data from a cyber attack pandemic. According to analyst firm IDC , 93% of pharmaceutical companies and 72% of biotech companies already have business-critical applications in the cloud, including product lifecycle management, analytics, revenue management, and much more.

article thumbnail

Delivering responsible AI in the healthcare and life sciences industry

IBM Big Data Hub

How can we proactively invest in AI for more equitable and trustworthy outcomes? Created by a respected Tennessee pharmaceutical firm, Elixir Sulfanilamide was a liquid medication touted to dramatically cure strep throat. As was common for the times, the drug was not tested for toxicity before it went to market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Privacy and Cybersecurity Top 10 for 2018

Data Matters

The Relentless Rise of Big Data and AI. As big data and AI make our lives easier and more of our quotidian activities are pushed online, cybersecurity and privacy issues will continue to be business enablers or business roadblocks. The Internet of Bodies. SEC on Cybersecurity and Rise of Shareholder Breach Litigation.

article thumbnail

Regulatory Update: NAIC Summer 2020 National Meeting

Data Matters

The current draft of the FAQ document addresses topics such as general background, the intersection of state insurance regulation and federal securities law regulation, how to satisfy the best interest standard of conduct, and insurer supervision and training requirements. 43R—Loan-Backed and Structured Securities.

article thumbnail

Regulatory Update: NAIC Summer 2021 National Meeting

Data Matters

Valuation of Securities (E) Task Force Adopts an Amendment to the Purposes and Procedures Manual to Add Instructions for Review of Funds. The P&P Manual currently grants the NAIC’s Securities Valuation Office (SVO) discretion when determining whether a fund’s use of derivatives is consistent with a fixed income-like security (i.e.,